{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:11:02Z","timestamp":1723507862836},"posted":{"date-parts":[[2024,7,18]]},"group-title":"In Review","reference-count":34,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,6,20]]},"abstract":"<title>Abstract<\/title>\n        <p>Health-related quality of life (HRQoL) measures individual well-being across physical, psychological, and social domains. Patients with predominantly antibody deficiency (PAD) are at risk for morbidity and mortality, however, the effect of these complications on HRQoL requires additional study. Patients with PAD were asked to voluntarily complete the Centers for Disease Control (CDC) HRQoL-14 Healthy Days Measure questionnaire. These results were compared to data from the CDC-initiated Behavioral Risk Factor Surveillance System (BRFSS), a cross-sectional questionnaire including questions from CDC-HRQOL-14. Statistical analyses included two-proportion Z-test, t-tests, and analysis of variance. 83 patients with PAD completed the survey. Patients were sub-stratified into mild (23.7%), moderate (35.5%), severe (40.8%), and secondary (8.4%) PAD. \"Fair or poor\" health status was reported in 52.6% of PAD patients. Mental health challenges\u2009\u2265\u200914 days\/month occurred in 25% of patients. Physical health issues\u2009\u2265\u200914 days\/month was reported in 44.7% of patients. Activity limitations were noted by 80.3% of patients. There were no statistically significant differences by PAD severity. Patients with autoinflammatory disease co-morbidities reported more mental health challenges compared to those without (78% vs. 54.3%, p\u2009=\u20090.02). Compared to the CDC-BRFSS data, significantly more patients with PAD reported \"fair or poor\" health status (53% vs 12.0%; p\u2009&lt;\u20090.0001), mental health challenges (24.1% vs 14.7%; p\u2009=\u20090.02), and poor physical health (44.6% vs 8.0%; p\u2009&lt;\u20090.0001). Patients with PAD had significantly reduced HRQoL compared to CDC-BRFSS respondents from a similar geographical region. Decreased HRQoL was prevalent across all PAD severity levels. Additional research is needed to improve HRQoL for patients with PAD.<\/p>","DOI":"10.21203\/rs.3.rs-4612913\/v1","type":"posted-content","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T20:27:10Z","timestamp":1721334430000},"source":"Crossref","is-referenced-by-count":0,"title":["A Cross-Sectional Study of Health-Related Quality of Life in Patients with Predominantly Antibody Deficiency\u00a0"],"prefix":"10.21203","author":[{"given":"Ahmed","family":"Elmoursi","sequence":"first","affiliation":[{"name":"Massachusetts General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baijun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Sing","family":"Ong","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Harvard Pilgrim Health Care Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph S.","family":"Hong","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Pak","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megha","family":"Tandon","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Sutherland","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel V.","family":"DiGiacomo","sequence":"additional","affiliation":[{"name":"Hackensack Meridian School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jocelyn R.","family":"Farmer","sequence":"additional","affiliation":[{"name":"Beth Israel Lahey Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Barmettler","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2009.03954.x","author":"Gathmann B","year":"2009","unstructured":"Gathmann B, Grimbacher B, Beaute J, Dudoit Y, Mahlaoui N, Fischer A et al. The European internet-based patient and research database for primary immunodeficiencies: results 2006\u20132008. Clin Exp Immunol. 2009;157(Suppl 1):3\u201311. 10.1111\/j.1365-2249.2009.03954.x. PMID: 19737289."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","article-title":"International union of immunological societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity","volume":"38","author":"Picard C","year":"2018","unstructured":"Picard C, Bobby Gaspar H, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, et al. International union of immunological societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity. J Clin Immunol. 2018;38:96\u2013128. 10.1007\/s10875-017-0464-9.","journal-title":"J Clin Immunol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nri3466","article-title":"Primary antibody deficiencies","volume":"13","author":"Durandy A","year":"2013","unstructured":"Durandy A, Kracker S, Fischer A. Primary antibody deficiencies. Nat Rev Immunol. 2013;13:519\u201333. 10.1038\/nri3466.","journal-title":"Nat Rev Immunol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.jaci.2010.02.040","article-title":"Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years","volume":"125","author":"Lucas M","year":"2010","unstructured":"Lucas M, Lee M, Lortan J, Lopez-Granados E, Misbah S, Chapel H. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol. 2010;125:1354\u2013e601354. 10.1016\/j.jaci.2010.02.040.","journal-title":"J Allergy Clin Immunol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10875-017-0465-8","article-title":"The 2017 IUIS phenotypic classification for primary immunodeficiencies","volume":"38","author":"Bousfiha A","year":"2018","unstructured":"Bousfiha A, Jeddane L, Picard C, Ailal F, Bobby Gaspar H, Al-Herz W, et al. The 2017 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol. 2018;38:129\u201343. 10.1007\/s10875-017-0465-8.","journal-title":"J Clin Immunol"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"136","author":"Bonilla FA","year":"2015","unstructured":"Bonilla FA, Khan DA, Ballas ZK, Chinen J, Frank MM, Hsu JT, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol. 2015;136(5):1186\u2013205. e1-78.","journal-title":"J Allergy Clin Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-821028-4.00006-3","volume-title":"Inborn Errors of Immunity","author":"Cheraghi T","year":"2021","unstructured":"Cheraghi T, Kalantari A, Shabestari MS, Abolhassani H, Eibel H, Hammarstr\u00f6m L. Inborn Errors of Immunity. 1st ed. Academic; 2021. 10.1016\/B978-0-12-821028-4.00006-3.","edition":"1"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7525-10-134","article-title":"Systematic review of health-related quality of life models","volume":"10","author":"Bakas T","year":"2012","unstructured":"Bakas T, Mclennon SM, Carpenter JS, Buelow JM, Otte JL, Hanna KM, et al. Systematic review of health-related quality of life models. Health Qual Life outcomes. 2012;10:1\u201312. 10.1186\/1477-7525-10-134.","journal-title":"Health Qual Life outcomes"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.joon.2004.11.001","article-title":"A concept analysis of quality of life","volume":"9","author":"Mandzuk LL","year":"2005","unstructured":"Mandzuk LL, McMillan DE. A concept analysis of quality of life. J Orthop Nurs. 2005;9:12\u20138. 10.1016\/j.joon.2004.11.001.","journal-title":"J Orthop Nurs"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/j.jaip.2019.02.013","article-title":"Health-related quality of life in children and adults with primary immunodeficiencies: a systematic review and meta-analysis","volume":"7","author":"Peshko D","year":"2019","unstructured":"Peshko D, Kulbachinskaya E, Korsunskiy I, Kondrikova E, Pulvirenti F, Quinti I, et al. Health-related quality of life in children and adults with primary immunodeficiencies: a systematic review and meta-analysis. J Allergy Clin Immunology: Pract. 2019;7:1929\u2013e575. 10.1016\/j.jaip.2019.02.013.","journal-title":"J Allergy Clin Immunology: Pract"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.2165\/00019053-200624120-00005","article-title":"Generic health-related quality-of-life assessment in children and adolescents: methodological considerations","volume":"24","author":"Ravens-Sieberer U","year":"2006","unstructured":"Ravens-Sieberer U, Erhart M, Wille N, Wetzel R, Nickel J, Bullinger M. Generic health-related quality-of-life assessment in children and adolescents: methodological considerations. PharmacoEconomics. 2006;24:1199\u2013220. 10.2165\/00019053-200624120-00005.","journal-title":"PharmacoEconomics"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2147\/PPA.S58040","article-title":"Health-related quality of life, anxiety, and depressive symptoms in children with primary immunodeficiencies","volume":"8","author":"Kuburovic NB","year":"2014","unstructured":"Kuburovic NB, Pasic S, Susic G, Stevanovic D, Kuburovic V, Zdravkovic S, et al. Health-related quality of life, anxiety, and depressive symptoms in children with primary immunodeficiencies. Patient Prefer Adherence. 2014;8:323\u201330. 10.2147\/PPA.S58040. PMID: 24672289. PMC: PMC3962398.","journal-title":"Patient Prefer Adherence"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7525-3-34","article-title":"Health-related quality of life measurement in pediatric clinical practice: an appraisal and precept for future research and application","volume":"3","author":"Varni JW","year":"2005","unstructured":"Varni JW, Burwinkle TM, Lane MM. Health-related quality of life measurement in pediatric clinical practice: an appraisal and precept for future research and application. Health Qual Life outcomes. 2005;3:1\u20139. 10.1186\/1477-7525-3-34.","journal-title":"Health Qual Life outcomes"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1371124","DOI":"10.3389\/fimmu.2024.1371124","article-title":"Health-related quality of life in patients with inborn errors of immunity: a bibliometric analysis","volume":"15","author":"Xiao N","year":"2024","unstructured":"Xiao N, Huang X, Zang W, Kiselev S, Bolkov MA, Tuzankina IA, Chereshnev VA. Health-related quality of life in patients with inborn errors of immunity: a bibliometric analysis. Front Immunol. 2024;15:1371124. 10.3389\/fimmu.2024.1371124.","journal-title":"Front Immunol"},{"issue":"2","key":"ref15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/cei.12485","article-title":"Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease","volume":"179","author":"Jolles S","year":"2015","unstructured":"Jolles S, Orange JS, Gardulf A, Stein MR, Shapiro R, Borte M, Berger M. Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease. Clin Exp Immunol. 2015;179(2):146\u201360. 10.1111\/cei.12485. PMID: 25384609; PMCID: PMC4298393.","journal-title":"Clin Exp Immunol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3389\/fimmu.2014.00605","article-title":"Longitudinal study on health-related quality of life in a cohort of 96 patients with common variable immune deficiencies","volume":"5","author":"Tabolli S","year":"2014","unstructured":"Tabolli S, Giannantoni P, Pulvirenti F, La Marra F, Granata G, Milito C, et al. Longitudinal study on health-related quality of life in a cohort of 96 patients with common variable immune deficiencies. Front Immunol. 2014;5:605. 10.3389\/fimmu.2014.00605.","journal-title":"Front Immunol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s10875-016-0279-0","article-title":"Health-related quality of life and health resource utilization in patients with primary immunodeficiency disease prior to and following 12 months of immunoglobulin G treatment","volume":"36","author":"Routes J","year":"2016","unstructured":"Routes J, Costa-Carvalho BT, Grimbacher B, Paris K, Ochs HD, Filipovich A, et al. Health-related quality of life and health resource utilization in patients with primary immunodeficiency disease prior to and following 12 months of immunoglobulin G treatment. J Clin Immunol. 2016;36:450\u201361. 10.1007\/s10875-016-0279-0.","journal-title":"J Clin Immunol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1007\/s10875-021-01013-7","article-title":"Severe fatigue is common among pediatric patients with primary immunodeficiency and is not related to disease activity","volume":"41","author":"Nijhof LN","year":"2021","unstructured":"Nijhof LN, van Brussel M, Pots EM, van Litsenburg RR, van de Putte EM, van Montfrans JM, et al. Severe fatigue is common among pediatric patients with primary immunodeficiency and is not related to disease activity. J Clin Immunol. 2021;41:1198\u2013207. 10.1007\/s10875-021-01013-7.","journal-title":"J Clin Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-022-01207-7","author":"Manusama OR","year":"2022","unstructured":"Manusama OR, van Beveren NJ, van Hagen PM, Drexhage HA, Dalm VA. Psychological symptoms in primary immunodeficiencies: a common comorbidity? J Clin Immunol. 2022;42:695-8. 10.1007\/s10875-022-01207-7. PMID: 35043302."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"100170","DOI":"10.1016\/j.bbih.2020.100170","article-title":"Self-reported cognitive impairment in individuals with Primary Immunodeficiency Disease","volume":"9","author":"Sowers KL","year":"2020","unstructured":"Sowers KL, Gayda-Chelder CA, Galantino ML. Self-reported cognitive impairment in individuals with Primary Immunodeficiency Disease. Brain Behav Immunity-Health. 2020;9:100170. 10.1016\/j.bbih.2020.100170.","journal-title":"Brain Behav Immunity-Health"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jacc.2004.12.005","article-title":"The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology","volume":"45","author":"Rozanski A","year":"2005","unstructured":"Rozanski A, Blumenthal JA, Davidson KW, Saab PG, Kubzansky L. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol. 2005;45:637\u201351. 10.1016\/j.jacc.2004.12.005.","journal-title":"J Am Coll Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1037\/0033-2909.131.2.260","article-title":"Anger, anxiety, and depression as risk factors for cardiovascular disease: the problems and implications of overlapping affective dispositions","volume":"131","author":"Suls J","year":"2005","unstructured":"Suls J, Bunde J. Anger, anxiety, and depression as risk factors for cardiovascular disease: the problems and implications of overlapping affective dispositions. psychol Bull. 2005;131:260. 10.1037\/0033-2909.131.2.260.","journal-title":"psychol Bull"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"109727","DOI":"10.1016\/j.jpsychores.2019.05.005","article-title":"Associations of fatigue and sleep disturbance with nine common mental disorders","volume":"123","author":"McCallum SM","year":"2019","unstructured":"McCallum SM, Batterham PJ, Calear AL, Sunderland M, Carragher N, Kazan D. Associations of fatigue and sleep disturbance with nine common mental disorders. J Psychosom Res. 2019;123:109727. 10.1016\/j.jpsychores.2019.05.005.","journal-title":"J Psychosom Res"},{"key":"ref24","article-title":"Population assessment of health-related quality of life","author":"Centers for Disease Control and Prevention Measuring Healthy Days","year":"2024","unstructured":"Centers for Disease Control and Prevention Measuring Healthy Days. Population assessment of health-related quality of life. Atlanta Ga CDC Apr. 2024. https:\/\/archive.cdc.gov\/#\/details?url=https:\/\/www.cdc.gov\/hrqol\/index.htm.","journal-title":"Atlanta Ga CDC Apr"},{"issue":"9","key":"ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6709a1","article-title":"Surveillance for Certain Health Behaviors and Conditions Among States and Selected Local Areas - Behavioral Risk Factor Surveillance System, United States, 2015","volume":"67","author":"Pickens CM","year":"2018","unstructured":"Pickens CM, Pierannunzi C, Garvin W, Town M. Surveillance for Certain Health Behaviors and Conditions Among States and Selected Local Areas - Behavioral Risk Factor Surveillance System, United States, 2015. MMWR Surveill Summ. 2018;67(9):1\u201390.","journal-title":"MMWR Surveill Summ"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12874-016-0255-7","article-title":"National weighting of data from the Behavioral Risk Factor Surveillance System (BRFSS)","volume":"16","author":"Iachan R","year":"2016","unstructured":"Iachan R, Pierannunzi C, Healey K, Greenlund KJ, Town M. National weighting of data from the Behavioral Risk Factor Surveillance System (BRFSS). BMC Med Res Methodol. 2016;16(1):155.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International Consensus Document (ICON): Common Variable Immunodeficiency Disorders","volume":"4","author":"Bonilla FA","year":"2016","unstructured":"Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, et al. International Consensus Document (ICON): Common Variable Immunodeficiency Disorders. J Allergy Clin Immunol Pract. 2016;4(1):38\u201359.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","article-title":"Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification","volume":"40","author":"Bousfiha A","year":"2020","unstructured":"Bousfiha A, Jeddane L, Picard C, Al-Herz W, Ailal F, Chatila T, et al. Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification. J Clin Immunol. 2020;40(1):66\u201381.","journal-title":"J Clin Immunol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1217718","DOI":"10.3389\/fimmu.2023.1217718","article-title":"Response to SARS-CoV-2 initial series and additional dose vaccine in pediatric patients with predominantly antibody deficiency","volume":"14","author":"Tandon M","year":"2023","unstructured":"Tandon M, DiGiacomo DV, Zhou B, Hesterberg P, Rosenberg CE, Barmettler S, Farmer JR. Response to SARS-CoV-2 initial series and additional dose vaccine in pediatric patients with predominantly antibody deficiency. Front Immunol. 2023;14:1217718. 10.3389\/fimmu.2023.1217718. PMID: 37575247; PMCID: PMC10413262.","journal-title":"Front Immunol"},{"issue":"2","key":"ref30","doi-asserted-by":"publisher","first-page":"100234","DOI":"10.1016\/j.jacig.2024.100234","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response in adults with predominantly antibody deficiency","volume":"3","author":"Zhang AM","year":"2024","unstructured":"Zhang AM, Elmoursi A, DiGiacomo DV, Zhou B, Tandon M, Hong JS, Yang NJ, Ong MS, Dighe AS, Berrios C, Poznansky MC, Iafrate AJ, Naranbhai V, Balazs A, Pillai S, Farmer JR, Barmettler S. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response in adults with predominantly antibody deficiency. J Allergy Clin Immunol Glob. 2024;3(2):100234. 10.1016\/j.jacig.2024.100234. PMID: 38544577; PMCID: PMC10965812.","journal-title":"J Allergy Clin Immunol Glob"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"20170037","DOI":"10.1515\/ijamh-2017-0037","article-title":"do C\u00e9u MaChado M. (Health-related) quality of life and psychosocial factors in adolescents with chronic disease: A systematic literature review","volume":"31","author":"Santos T","year":"2017","unstructured":"Santos T, de Matos MG, Sim\u00f5es C, Leal I. do C\u00e9u MaChado M. (Health-related) quality of life and psychosocial factors in adolescents with chronic disease: A systematic literature review. Int J Adolesc Med Health. 2017;31:20170037. 10.1515\/ijamh-2017-0037.","journal-title":"Int J Adolesc Med Health"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1016\/j.amepre.2019.09.007","article-title":"Association of psychosocial factors with risk of chronic diseases: A nationwide longitudinal study","volume":"58","author":"Sahle BW","year":"2020","unstructured":"Sahle BW, Chen W, Melaku YA, Akombi BJ, Rawal LB, Renzaho AM. Association of psychosocial factors with risk of chronic diseases: A nationwide longitudinal study. Am J Prev Med. 2020;58:e39\u201350. 10.1016\/j.amepre.2019.09.007.","journal-title":"Am J Prev Med"},{"issue":"4","key":"ref33","first-page":"A78","article-title":"Racial\/ethnic and socioeconomic disparities in health-related quality of life among people with coronary heart disease, 2007","volume":"8","author":"Hayes DK","year":"2011","unstructured":"Hayes DK, Greenlund KJ, Denny CH, Neyer JR, Croft JB, Keenan NL. Racial\/ethnic and socioeconomic disparities in health-related quality of life among people with coronary heart disease, 2007. Prev Chronic Dis. 2011;8(4):A78. Epub 2011 Jun 15. PMID: 21672402; PMCID: PMC3136984.","journal-title":"Prev Chronic Dis"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-019-02157-1","author":"Wallander JL","year":"2019","unstructured":"Wallander JL, Fradkin C, Elliott MN, Tortolero S, Cuccaro P, Schuster MA. Racial\/ethnic disparities in health-related quality of life and health status across pre-, early-, and mid-adolescence: a prospective cohort study. Qual Life Res. 2019;28:1761\u20131771. 10.1007\/s11136-019-02157-1. PMID: 30788576."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4612913\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4612913\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T16:27:57Z","timestamp":1723480077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4612913\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":34,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-4612913\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1007\/s10875-024-01781-y","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,7,18]]},"subtype":"preprint"}}